You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 71930-0046


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 71930-0046

Drug NameNDCPrice/Unit ($)UnitDate
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET 71930-0046-12 0.22992 EACH 2025-03-19
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET 71930-0046-52 0.22992 EACH 2025-03-19
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET 71930-0046-12 0.22062 EACH 2025-02-19
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET 71930-0046-52 0.22062 EACH 2025-02-19
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET 71930-0046-52 0.20534 EACH 2025-01-22
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET 71930-0046-12 0.20534 EACH 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for NDC 71930-0046

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
OXYCODONE HCL 7.5MG/ACETAMINOPHEN 325MG TAB Golden State Medical Supply, Inc. 71930-0046-12 100 13.41 0.13410 2023-06-16 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for NDC 71930-0046: Oxycodone HCL

Introduction to Oxycodone HCL

Oxycodone hydrochloride, identified by the NDC 71930-0046, is a potent opioid analgesic used for the management of moderate to severe pain. This drug is part of a broader class of opioids that have seen significant demand due to the ongoing need for effective pain management solutions.

Market Overview

The market for oxycodone hydrochloride is characterized by several key factors:

Increasing Demand

The demand for pain management solutions continues to rise, driven by an ageing population and an increase in chronic pain conditions. This sustained demand is a significant driver for the oxycodone hydrochloride market[1].

Regulatory Environment

Regulatory efforts, such as the Medicare Drug Price Negotiation Program, can exert downward pressure on drug prices. However, these effects may be more pronounced in the long term and could impact the pricing of oxycodone hydrochloride[2].

Supply Chain Stability

The availability of oxycodone hydrochloride from various manufacturers, including Golden State Medical Supply, Inc., helps maintain market stability. Any disruptions in the supply chain, such as the discontinuation of certain strengths by major manufacturers, could lead to temporary price increases[1][2].

Price Projections

Impact of Shortages

Recent discontinuations of certain strengths by major manufacturers could lead to temporary price increases due to reduced supply. However, the presence of products from other manufacturers helps mitigate this impact[2].

Regulatory Influence

Regulatory efforts aimed at reducing drug prices may exert downward pressure on the prices of oxycodone hydrochloride. For example, the Medicare Drug Price Negotiation Program could lead to predictable, albeit small, price adjustments over time[2].

Market Demand

The ongoing demand for pain management solutions is likely to sustain the market for oxycodone hydrochloride. This demand could stabilize prices despite regulatory pressures[2].

Key Factors Influencing Pricing

Utilization and New Products

While increased utilization and the introduction of new drugs can drive up prices, the primary drivers for oxycodone hydrochloride are likely to be supply chain stability and regulatory changes rather than new product introductions[2].

Price Adjustments

Prices for oxycodone hydrochloride may be adjusted annually based on the Consumer Price Index (CPI-U) if they are included in future negotiation programs. This could lead to small, predictable price increases over time[2].

Industry Expert Insights

Industry experts emphasize the importance of navigating regulatory changes and maintaining supply chain stability to ensure market stability and profitability.

"The pharmaceutical industry is expected to grow robustly, driven by ageing populations and emerging markets. However, drug pricing regulation could impact the industry, and companies must navigate these changes carefully to maintain profitability."[2]

Current Pricing Trends

As of the latest data, the prices for oxycodone hydrochloride solutions and tablets vary based on the strength and vendor. For example, the price per unit for oxycodone HCL 5 MG/5 ML solution can range from $0.06499 to $0.07313 per milliliter, depending on the vendor and the specific product[1].

Statistical Analysis

  • Price Increases: Over the period from January 2022 to January 2023, more than 4,200 drug products had price increases, with 46% of these increases exceeding the rate of inflation. The average drug price increase was 15.2%, translating to $590 per drug product[4].
  • Supply and Demand: The sustained demand for pain management solutions ensures a stable market for oxycodone hydrochloride, despite potential regulatory and supply chain pressures[1][2].

Illustrative Statistics

  • Average Price Increase: The average price increase for prescription drugs from January 2022 to January 2023 was 15.2%, which is nearly 3.5 times the average price change between 2021 and 2022[4].
  • Supply Chain Impact: The availability of products from manufacturers like Eywa Pharma Inc. helps mitigate the impact of supply chain disruptions, ensuring market stability[2].

Expert Predictions for 2025

While specific predictions for oxycodone hydrochloride are not detailed, broader pharmaceutical trends suggest an increased adoption of artificial intelligence (AI) in clinical development and the use of reliable external data to train internal data science models. These trends could indirectly influence pricing and market dynamics by improving efficiency and reducing costs[3].

Key Takeaways

  • Supply Chain Stability: The availability of oxycodone hydrochloride from multiple manufacturers is crucial for maintaining market stability.
  • Regulatory Influence: Regulatory efforts, such as the Medicare Drug Price Negotiation Program, could exert downward pressure on prices.
  • Market Demand: Ongoing demand for pain management solutions will continue to drive the market.
  • Price Adjustments: Prices may be adjusted annually based on CPI-U if included in future negotiation programs.

FAQs

What are the primary drivers of the oxycodone hydrochloride market?

The primary drivers include increasing demand for pain management solutions, supply chain stability, and regulatory changes.

How do regulatory efforts impact the pricing of oxycodone hydrochloride?

Regulatory efforts, such as the Medicare Drug Price Negotiation Program, can exert downward pressure on prices and lead to predictable price adjustments over time.

What is the impact of supply chain disruptions on oxycodone hydrochloride prices?

Supply chain disruptions, such as the discontinuation of certain strengths by major manufacturers, could lead to temporary price increases due to reduced supply.

How does the ageing population affect the market for oxycodone hydrochloride?

The ageing population contributes to an increased demand for pain management solutions, which sustains the market for oxycodone hydrochloride.

What role does AI play in the pharmaceutical industry, and how might it affect oxycodone hydrochloride?

AI is increasingly adopted in clinical development and data analysis, which could improve efficiency and reduce costs, indirectly influencing pricing and market dynamics.

Cited Sources:

  1. DrugPatentWatch, "Drug prices and trends for OXYCODONE HCL".
  2. DrugPatentWatch, "Latest drug prices and trends for NDC 71930-0024".
  3. Intelligencia.ai, "2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch".
  4. ASPE, "Changes in the List Prices of Prescription Drugs, 2017-2023".
  5. FDA.report, "NDC 71930-043 Oral Tablet hydrocodone bitartrate".

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.